QTX-2101

N/A

Report date: 2026/04/14 20:00:15
NME

Base Information

Drug NameQTX-2101
Drug Alias NameQTX-2101
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLeukemia, Promyelocytic, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesQuetzal Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesQuetzal Therapeutics
Inactive CompaniesN/A
Active IndicationsLeukemia, Promyelocytic, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A